Anti-GSK3B Magnetic Beads Immunoprecipitation (IP) Kit

Temporarily not available outside of China.

抗GSK3B 磁気ビーズ免疫沈降(IP)キットの成分

Components Storage
Anti-GSK3B Magnetic Beads1,3 2-8℃ for 12 months
NP40 Cell Lysis Buffer2 -20℃ for 12 months
Alkaline Elution Buffer 2-8℃ for 12 months
Acidity Elution Buffer 2-8℃ for 12 months
Neutralization Buffer 2-8℃ for 12 months

【1】The IP KIT contains anti-GSK3B magnetic Beads (2 mg/mL) in phosphate buffered saline (PBS, pH 7.4) with sodium azide (0.1%).

【2】Using NP-40 cell lysate buffer in the kit is required,otherwise,the magnetic beads may be precipitated.

【3】Shipping: Magnetic Beads kits are shipped at ambient temperature in which magnetic beads are provided in liquid buffer.

抗GSK3B 磁気ビーズ免疫沈降(IP)キットの製品説明

The Anti-GSK3B magnetic Beads, conjugated with Anti-GSK3B antibody, are used for immuneprecipitation (IP) of GSK3B proteins which expressed in vitro expression systems. For IP, the beads are added to a sample containing GSK3B proteins to form a bead-protein complex. The complex is removed from the solution manually using a magnetic separator. The bound GSK3B proteins are dissociated from the magnetic beads using an elution buffer.

抗GSK3B 磁気ビーズ免疫沈降(IP)キット抗体の情報

Anti-GSK3B Antibody(201088-T36)
E. coli-derived Human GSK3B fragment
Human GSK3B
Polyclonal Human Rabbit IgG
Produced in rabbits immunized with E. coli-derived Human GSK3B fragment, and purified by antigen affinity chromatography.
Immunoprecipitation (IP), Minimum Protein Purification

GSK3B 背景情報

GSK3B is a serine-threonine kinase, belonging to the glycogen synthase kinase subfamily. It Contains 1 protein kinase domain, and is expressed in testis, thymus, prostate and ovary and weakly expressed in lung, brain and kidney. GSK3B is involved in energy metabolism, neuronal cell development, and body pattern formation. Polymorphisms in GSK3B gene have been implicated in modifying risk of Parkinson disease, and studies in mice show that overexpression of this gene may be relevant to the pathogenesis of Alzheimer disease. GSK3B participates in the Wnt signaling pathway. It is implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates MUC1 in breast cancer cells, and decreases the interaction of MUC1 with CTNNB1/beta-catenin. GSK3B also plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. GSK3B phosphorylates MACF1 and this phosphorylation inhibits the binding of MACF1 to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. It may be required for early embryo development and neuron differentiation.
glycogen synthase kinase 3 beta
Related Pathways
  • Canonical Wnt Pathway
    Canonical Wnt Pathway
  • NF-kB (NFkB) Pathway
    NF-kB (NFkB) Pathway
  • p53 Pathway
    p53 Pathway
  • AKT Signaling Pathway
    AKT Signaling Pathway
  • AMPK Signaling Pathway
    AMPK Signaling Pathway
  • B Cell Receptor Signaling Pathway
    B Cell Receptor Signaling Pathway
  • MAPK-Erk Pathway
    MAPK-Erk Pathway
  • IL17 signaling pathway
    IL17 signaling pathway
  • Bergmann C, et al. (2011) Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway. Ann Rheum Dis. 70(12):2191-8.
  • Ban JO, et al. (2011) Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression. Cancer Biol Ther. 12(4):288-96.
  • Tsukigi M, et al. (2012) Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β. Cancer Lett. 315(2):189-97.
  • Nandan D, et al. (2012) Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3 kinase. J Immunol. 188(1):367-78.
カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください U.S.A.